|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,600.00 KRW | 0.00% |
|
+9.17% | -69.83% |
| Market Cap | 204B 145M 125M 117M 107M 202M 13.79B 205M 1.37B 539M 6.91B 544M 532M 22.85B | P/E 2024 |
-2.95x | P/E 2025 | 28.3x |
|---|---|---|---|---|---|
| Enterprise Value | 297B 211M 182M 170M 156M 294M 20.08B 299M 2B 785M 10.06B 792M 775M 33.27B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 3.64x |
| Free-Float |
58.13% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +9.17% | ||
| Current month | +9.17% | ||
| 1 month | -61.95% | ||
| 3 months | -75.55% | ||
| 6 months | -75.62% | ||
| Current year | -69.83% |
| 1 week | 13,910 |  | 19,120 |
| 1 month | 13,210 | | 43,200 |
| Current year | 13,210 | | 72,700 |
| 1 year | 13,210 | | 72,700 |
| 3 years | 13,210 | | 72,700 |
| 5 years | 13,210 | | 72,700 |
| 10 years | 11,000 | | 127,600 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seon-Jin Kim
CEO | Chief Executive Officer | 65 | 2023-03-27 |
Yeong-U Jo
PRN | Corporate Officer/Principal | 59 | 2016-06-30 |
Jong-Won Kim
AUD | Comptroller/Controller/Auditor | 67 | 2024-03-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Yeong-U Jo
BRD | Director/Board Member | 59 | 2021-03-24 |
Seon-Jin Kim
BRD | Director/Board Member | 65 | 2023-03-27 |
Seok-Jung Yun
BRD | Director/Board Member | 59 | 2023-03-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +9.17% | -50.48% | -42.86% | 145M | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +1.02% | +1.30% | +25.33% | +35.59% | 362.09B | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.72% | +64.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 161B 115M 99.05M 92.49M 84.85M 160M 10.9B 162M 1.09B 426M 5.46B 430M 421M 18.06B | 209B 148M 128M 120M 110M 207M 14.11B 210M 1.41B 552M 7.07B 557M 545M 23.38B |
| Net income | -93.09B -66.04M -57.13M -53.35M -48.94M -92.05M -6.29B -93.51M -626M -246M -3.15B -248M -243M -10.42B | 24.96B 17.71M 15.32M 14.31M 13.12M 24.68M 1.69B 25.07M 168M 65.87M 845M 66.5M 65.05M 2.79B |
| Net Debt | 114B 80.95M 70.02M 65.39M 59.99M 113M 7.7B 115M 767M 301M 3.86B 304M 297M 12.77B | 93.09B 66.05M 57.13M 53.35M 48.94M 92.06M 6.29B 93.52M 626M 246M 3.15B 248M 243M 10.42B |
Employees
425
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | ₩15,600.00 | 0.00% | 159,885 |
| 26-08-06 | ₩15,600.00 | -4.18% | 235,767 |
| 26-08-05 | ₩16,280.00 | +5.37% | 1,174,864 |
| 26-08-04 | ₩15,450.00 | +4.25% | 252,514 |
| 26-08-03 | ₩14,820.00 | +3.71% | 296,744 |
- Stock Market
- Stocks
- A102940 Stock
Select your edition
All financial news and data tailored to specific country editions
